Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
ERNA

Overview Financials Analysis Smart Money

Ernexa Therapeutics Inc.

ERNA · NASDAQ

Analyze with AI

Filings1

Total reported value$18.6K

Manager	Shares	Value	Change
BlackRock Inc.	15K	$18.6K	-4.5%

SymbolERNA

Market Cap$9.7M

IPO Date1991-08-29

CEOSanjeev Luther

Employees6

SectorHealthcare

IndustryBiotechnology

CountryUS

ExchangeNASDAQ Global Market

Athira Pharma, Inc.

ATHA

$6.91

+66.99%

Sable Offshore Corp.

SOC

$8.79

+66.48%

urban-gro, Inc.

UGRO

$0.4341

+46.66%

FuelCell Energy, Inc.

FCEL

$10.56

+33.67%

Trump Media & Technology Group Corp.

DJT

$13.90

+32.78%

Peers

Adaptimmune Therapeutics plc

ADAP · NASDAQ

$0.0485

-3.00%

MapLight Therapeutics, Inc.

MPLT · NASDAQ

$19.99

+1.78%

Lunai Bioworks Inc.

LNAI · NASDAQ

$1.04

+5.51%

ProMIS Neurosciences, Inc.

PMN · NASDAQ

$8.80

-1.35%

Dogwood Therapeutics, Inc.

DWTX · NASDAQ

$6.51

+0.39%

BiomX Inc.

PHGE · AMEX

$1.71

+0.22%

Moleculin Biotech, Inc.

MBRX · NASDAQ

$4.08

-1.38%

AEON Biopharma, Inc.

AEON · AMEX

$0.9656

-0.45%

OSR Holdings, Inc.

OSRH · NASDAQ

$0.56

+3.26%

Aethlon Medical, Inc.

AEMD · NASDAQ

$2.96

+3.96%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.